Relmada Therapeutics Other Long Term Liabilities (Quarterly) Trends

Relmada Therapeutics, Inc. (RLMD)

4.06 -0.05 (-1.22%) USD | NASDAQ | Jan 13, 16:00

3.99 -0.07 (-1.72%) Pre-Market: 08:34

View Other Long Term Liabilities (Quarterly) for RLMD.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Amicus Therapeutics, Inc.	Upgrade
Invivyd, Inc.	--
Arcellx, Inc.	--
Puma Biotechnology, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	--